Holly Shalhoop, PA
Physician Assistant · Cumming, GANPI 1578867040
Payments from drug & device makers
Across 191 payments — averaging $25.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$442
- Pfizer$440
- Bayer$404
- Axonics, Inc.$298
- Astellas Pharma US Inc$268
- Teleflex LLC$256
- plus $3K from 34 others
What the payments were for
- Travel & lodging$110%
- Food & beverage$4,74396%
- Education$2114%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $442 |
| Pfizer | 21 | $440 |
| Bayer | 18 | $404 |
| Axonics, Inc. | 8 | $298 |
| Astellas Pharma US Inc | 10 | $268 |
| Teleflex LLC | 4 | $256 |
| Ferring Pharmaceuticals Inc. | 11 | $254 |
| Myriad Genetic Laboratories, Inc. | 6 | $241 |
| Sumitomo Pharma America, Inc. | 9 | $212 |
| Merck | 8 | $207 |
| SRS Medical Systems, Inc. | 1 | $185 |
| Johnson & Johnson | 3 | $156 |
| Myovant Sciences Inc. | 7 | $154 |
| Urogen Pharma, Inc. | 6 | $152 |
| Tempus AI, Inc | 4 | $112 |
| Progenics Pharmaceuticals, Inc. | 1 | $111 |
| Medtronic | 5 | $106 |
| Endo USA, Inc. | 4 | $95 |
| Coloplast | 5 | $94 |
| Endo Pharmaceuticals Inc. | 4 | $93 |
| Boston Scientific | 3 | $74 |
| Antares Pharma, Inc. | 4 | $70 |
| Dendreon Pharmaceuticals LLC | 3 | $65 |
| Baxter Healthcare | 2 | $62 |
| Acerus Pharmaceuticals Corporation | 3 | $58 |
| Kowa Pharmaceuticals America, Inc. | 3 | $57 |
| Vertex | 2 | $51 |
| Blue Earth Diagnostics | 2 | $42 |
| Angiodynamics, Inc. | 1 | $35 |
| Verity Pharmaceuticals Inc. | 1 | $23 |
| Tolmar Pharmaceuticals, Inc. | 1 | $21 |
| Procept Biorobotics Corporation | 1 | $19 |
| Ambu Inc. | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Laborie Medical Technologies Corp. | 1 | $15 |
| Tolmar, Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
| 180 Medical, Inc. | 1 | $14 |
| AbbVie | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,965 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 15 | $211,035 |
| MyrbetriqMirabegron | 126 | $87,060 |
| GemtesaVibegron | 71 | $56,718 |
| Tamsulosin Hcl | 261 | $3,224 |
| Trospium Chloride ErTrospium Chloride | 17 | $2,505 |
| Solifenacin Succinate | 44 | $1,662 |
| Oxybutynin Chloride ErOxybutynin Chloride | 82 | $1,653 |
| Estradiol | 24 | $1,389 |
| Methenamine Hippurate | 22 | $1,377 |
| Darifenacin ErDarifenacin Hydrobromide | 12 | $1,239 |
| Potassium Citrate ErPotassium Citrate | 14 | $907 |
| Finasteride | 50 | $623 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 47 | $528 |
| Testosterone Cypionate | 12 | $473 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 56 | $426 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $156 | $211,03515 claims |
| Astellas Pharma US IncMyrbetriq | $268 | $87,060126 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $212 | $56,71871 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Cumming
- Amanda ApplingCumming$19K
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Joseph LangshawCalhoun$887K
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Lisa HillMarietta$190K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.